NEW YORK (AVAFIN) -- Ariad Pharmaceuticals options established a new 90-day record for traded call and put contracts. A total of 4,160
put and 6,142 call contracts were traded raising a 0.68 put/call ratio on shares of ARIA
View Options Trading Activities
A significant increase in the trading volume of a stock's option often is a precursor of movement
by the underlying stock. In such instances, put/call Ratio can be used as an investor sentiment
indicator, where a high ratio implies that the overall investor sentiment is bearish and a low
put/call ratio implies that the sentiment is bullish.
Shares of ARIA closed at $18.43 during the previous session. During the session,
the stock hit a low of $17.60 and high of $19.64. The current trading volume of 8M is
greater than average volume of 2M shares. ARIA is trading above
the 50 day moving average and lower than the 200 day moving average.
The stock's 52 week low is $15.13 and 52 week high is $25.40. To date, the stock has lost -5.29% within the last month.
View Best Performing Stocks
Ariad Pharmaceuticals Inc is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.